Skip to main content

Additional Depositions Granted for Pa. TVM Lawsuits

Additional Depositions Granted for Pa. TVM Lawsuits

Additional Depositions Granted for Pa. TVM Lawsuits

Introduction

The Philadelphia Court of Common Pleas overruled a motion filed by J&J subsidiary Ethicon requesting the court to decline the deposition notices that the Transvaginal mesh lawsuit plaintiffs had sent to company officials and included Ethicon's own strategic sourcing manager. Based on the Bristol-Myers Squibb decision, Ethicon had demanded 90 cases to be ousted as they were filed in the Philadelphia court by out-of-state plaintiffs, which left around 30 cases in the kitty. The plaintiffs put forth a strong argument stating that the plastic mesh materials used in the Ethicon mesh implants were supplied by Secant located in Bucks County, Pennsylvania. A Pennsylvania judge granted a limited depositions grant of a corporate designee and the strategic sourcing manager for Ethicon, Inc. The company has faced four previous defeats when it was ordered by the jury to pay a total nearing $48 million to Ethicon transvaginal mesh plaintiffs.

TVM lawsuits allege that the manufacturers failed to properly test their products and did not provide adequate warnings regarding the risks associated with the devices including the lack of any human trial by-passing the 510(K) approval way. Lawsuits are filed against a number of manufacturers, including American Medical Systems, Inc., Boston Scientific Corp, and C.R. Bard, Inc

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!